Tech.euEurope
Why do some patients respond to drugs and others don't? Switchpoint Bio raises $5.3M to find out

Emerging from stealth, Helsinki-Cambridge biotech startup Switchpoint Bio has raised $5.3 million in a pre-seed financing round, including a $5 million investment from Treehouse Delmar Investments.
Read at Tech.eu ↗Related

EuropeCzech medtech Kardi Ai raises €5.3M to advance predictive heart monitoring Tech.eu

EuropeAnthropic to raise $64BN in landmark US IPO Tech.eu

EuropeElomia Health acquires Earkick to expand AI mental wellbeing platform Tech.eu

EuropeCreandum leads $8.5M funding for Ancep to turn overlooked insurance risks into revenue Tech.eu

EuropeToo much research, too few startups: Noctua raises €15M to close Austria's deeptech gap Tech.eu
